Hypothesis

Eosinophil‑derived IL‑4 lowers nociceptor sensitization and thereby raises pain tolerance, while simultaneously slowing epigenetic aging in peripheral tissues.

Mechanistic Rationale

Aging reduces eosinophil numbers in adipose and muscle, cutting IL‑4 supply. Low IL‑4 lets pro‑inflammatory macrophages rise, increasing IL‑1β and TNF‑α that activate TRPV1 and Nav1.8 channels on sensory neurons, lowering pain threshold. At the same time, IL‑4 deficiency diminishes STAT6 signaling in fibroblasts and satellite cells, shifting the tissue transcriptome toward a senescence‑associated secretory phenotype (SASP) that accelerates DNA‑methylation drift measured by Horvath and Hannum clocks. Thus, eosinophil loss couples heightened pain sensitivity with faster biological age.

Predictions

1. In young mice, eosinophil depletion via anti‑IL‑5 antibody will decrease pain hot‑plate latency and increase hippocampal‑cortical EEG markers of affective pain, while blood‑DNA methylation age will rise faster than controls over 4 weeks.
2. Adoptive transfer of young eosinophils into aged mice will raise pain tolerance, reduce SASP cytokine levels in muscle and fat, and decelerate epigenetic aging relative to untreated aged littermates.
3. In humans, serum IL‑4 concentration will positively correlate with pressure‑pain threshold and negatively correlate with GrimAge acceleration after adjusting for age, sex, and BMI.

Experimental Design

Mouse arm: Use C57BL/6J mice aged 3 mo (young) and 18 mo (old). Groups: (a) IgG control, (b) anti‑IL‑5 to deplete eosinophils, (c) anti‑IL‑5 + recombinant IL‑4 rescue, (d) eosinophil transfer from young donors into old recipients. Measure von Frey and hot‑plate thresholds weekly, collect serum for IL‑4, IL‑5, eosinophil counts, and harvest tibialis anterior and epididymal fat for flow cytometry, qPCR of SASP genes (Il6, Ccl2), and bulk DNA‑methylation arrays. Compute epigenetic age with Horvath and Hannum algorithms.

Human arm: Recruit 120 adults aged 40‑70 y. Obtain fasting blood for eosinophil count, IL‑4 ELISA, and plasma for GrimAge. Perform pressure‑pain threshold testing with a computerized algometer on the tibialis anterior. Use linear models to test IL‑4 as predictor of pain tolerance and age acceleration.

Falsifiability

If eosinophil depletion does not alter pain thresholds or epigenetic age, or if IL‑4 rescue fails to restore tolerance and methylation profiles, the hypothesis is refuted. Likewise, a lack of correlation between serum IL‑4 and pain‑threshold/GrimAge in humans would falsify the proposed link.